Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Dossier - 20/12/2012 19018_de.jpg

    Medical technology – serving healthcare

    Modern healthcare would be impossible without medical technology. The achievements in medical technology are indispensable for our health and quality of life. The range of medical technology available covers surgical instruments and implants to diagnostic methods and medical devices.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/medical-technology-serving-healthcare
  • Article - 17/12/2012 18923_de.jpg

    Medicyte GmbH – gold standard for human cells

    Medicyte GmbH is a life sciences company located in the city of Heidelberg. It focuses primarily on the production of quasi-primary human cells of the highest quality and in virtually unlimited quantity. MediCyte’s goal is to establish its proprietary cell proliferation technologies as gold standard for the use of human cells and cell products in research, development and cell therapy.

    https://www.gesundheitsindustrie-bw.de/en/article/news/medicyte-gmbh-gold-standard-for-human-cells
  • Article - 08/10/2012 18286_de.jpg

    Epilepsy changes brain architecture

    Epileptic fits, i. e. abnormal excessive neuronal activity in the hippocampus, severely affects nerve cells and can lead to permanent damage. A team of researchers led by Prof. Dr. Carola Haas from the Neurocenter at the University of Freiburg is focusing on changes in the brain anatomy of patients suffering from temporal lobe epilepsy as well as on the molecular and cellular processes underlying the disease. The team’s research focuses on stem…

    https://www.gesundheitsindustrie-bw.de/en/article/news/epilepsy-changes-brain-architecture
  • Press release - 28/09/2012 European Flag

    Safer, more effective and innovative medical devices

    Ranging from simple sticking plasters to the most sophisticated life-supporting machines medical devices and in vitro diagnostic medical devices are central to our health and quality of life. To ensure that these devices serve the needs and ensure the safety of European citizens the European Commission proposed two Regulations which are fit for purpose more transparent and better adapted to scientific and technological progress.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/safer-more-effective-and-innovative-medical-devices
  • Article - 18/09/2012 18061_de.jpg

    Michael Kühl: in search of the gene architects of the heart

    Michael Kühl is investigating the development of the heart using a broad range of different model organisms. The developmental biologist, director of the Institute of Biochemistry and Molecular Biology at the University of Ulm, also uses evolutionary and systems biology approaches for his work. Kühl’s basic research does not follow an art for art’s sake principle, but also addresses the development of new therapies for the treatment of heart…

    https://www.gesundheitsindustrie-bw.de/en/article/news/michael-kuehl-in-search-of-the-gene-architects-of-the-heart
  • Press release - 06/07/2012 Money

    Medicyte is receiving 4.2 Mio Euros from the European Union Seventh Framework Programm

    Medicyte, The Electrospinning Company and the Universities of Manchester and Pisa launch a European wide unique project with the aim to design a biomimetic bioartificial liver (Re-Liver). The company GABO:mi ensures professional project management. Research is receiving 4.2 Mio Euros from the European Union Seventh Framework Programme.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/medicyte-is-receiving-4-2-mio-euros-from-the-european-union-seventh-framework-programm
  • Article - 21/05/2012 17138_de.jpg

    Microchip facilitates bowel movements

    Faecal incontinence is a common problem, but is still a strong taboo. A small microchip, implanted above the sacral bone, promises to make sufferers’ lives a lot easier. Sacral nerve stimulation (SNS) not only restores patients’ ability to control defaecation, but also provides new insights into the innervation and physiology of the bowel and the pelvic floor.

    https://www.gesundheitsindustrie-bw.de/en/article/news/microchip-facilitates-bowel-movements
  • Dossier - 26/03/2012 Diagram showing how proteins (cyan) can enclose a nanoparticle (green) that can bind on the cell membrane to receptors (blue), for example, in the same way free proteins.

    Nanobiotechnology

    The term nanotechnology is known by well over 50 of Germans especially since the lotus effect hit the headlines in the late 1990s. Around the turn of the millennium bio was inserted between nano and technology and nanobiotechnology has since taken up more and more room in the headlines as well as requiring major financial investment. What is nanobiotechnology what is the difference between nanotechnology and nanobiotechnology and where and what…

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/nanobiotechnology
  • Article - 19/03/2012 16673_de.jpg

    When the “second brain” fails – therapeutic options from the field of regenerative medicine

    Researchers from the Center for Regenerative Biology and Medicine ZRM in Tübingen are focused on the enteric nervous system of the gastrointestinal tract with the aim of developing cell-based therapies for the treatment of bowel diseases. The researchers are working with local partners in a BMBF-funded project that is seeking to develop therapies for Hirschsprung’s disease.

    https://www.gesundheitsindustrie-bw.de/en/article/news/when-the-second-brain-fails-therapeutic-options-from-the-field-of-regenerative-medicine
  • Dossier - 12/03/2012 16658_de.jpg

    Regenerative medicine makes use of patients’ own resources

    Regenerative medicine offers new therapeutic options for many diseases in which organ function or structure are damaged or lost. The majority of regenerative therapies involve cell-based methods that are often combined with innovative biomaterials. Regenerative therapies combine know-how from the biosciences with state-of-the-art medical technology and also benefit from progress in the engineering and material sciences.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/regenerative-medicine-makes-use-of-patients-own-resources
  • Press release - 07/03/2012 16615_de.jpg

    Implant to replace defective venous valve

    If heart valves don’t close properly, they are replaced. Conventional treatment of venous valve failure, however, has up to now always and exclusively been via medication. In future, an implant will assume the function of damaged valves. In close collaboration with other partners researchers from the Fraunhofer Institute for Manufacturing Engineering and Automation IPA in Stuttgart developed an automated production facility that can make venous…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/implant-to-replace-defective-venous-valve
  • Article - 23/01/2012 16231_de.jpg

    Karen Lienkamp: intelligent surface materials fight off microbes

    Resistant germs are tough and will settle anywhere. They grow on all types of surface which is a major cause for concern for medical doctors and industrial researchers alike. The chemist Dr. Karen Lienkamp Junior Fellow at the Freiburg Institute for Advanced Studies FRIAS and head of a group of junior researchers at the University of Freiburg develops surface materials for biomedical applications and industrial production facilities.

    https://www.gesundheitsindustrie-bw.de/en/article/news/karen-lienkamp-intelligent-surface-materials-fight-off-microbes
  • Article - 16/01/2012 Dr. Alexander Titz, chemist at the University of Konstanz

    Alexander Titz: molecular design to combat antibiotic-resistant bacteria

    Pseudomonas aeruginosa has become an important cause of infection, and is often picked up in hospitals, especially by patients with weakened immune systems. It can cause respiratory and urinary tract infections, as well as lead to infections on implants and wounds. P. aeruginosa lives in a gel-like matrix, a so-called biofilm that is highly resistant to antibiotics, making it very difficult to eradicate. Dr. Alexander Titz and his team at the…

    https://www.gesundheitsindustrie-bw.de/en/article/news/alexander-titz-molecular-design-to-combat-antibiotic-resistant-bacteria
  • Article - 09/01/2012 16145_de.jpg

    Parkinson’s disease – a fatal cycle of falling and rising activity in the basal ganglia

    As the disease progresses Parkinsons patients find it increasingly difficult to voluntarily control body movements. The disease is associated with oscillations of electrical activity in specific brain areas known as basal ganglia. Dr. Arvind Kumar and his colleagues at the Bernstein Center Freiburg have used neuronal network simulations to develop a model to explain these rhythmic oscillations.

    https://www.gesundheitsindustrie-bw.de/en/article/news/parkinson-s-disease-a-fatal-cycle-of-falling-and-rising-activity-in-the-basal-ganglia
  • Article - 06/12/2011 15973_de.jpg

    Bridging the gap between academia and industry

    Prof. Dr. Katja Schenke-Layland divides her work equally between the Stuttgart-based Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, where she is the deputy head of the Department of Cell Systems, and the University Hospital in Tübingen where she teaches and researches the use of biomaterials in the field of regenerative medicine at the Department of Thoracic, Cardiac and Vascular Surgery. By working between the two…

    https://www.gesundheitsindustrie-bw.de/en/article/news/bridging-the-gap-between-academia-and-industry
  • Press release - 30/09/2011 15269_de.jpg

    Blood Vessels from Your Printer

    Researchers have been working at growing tissue and organs in the laboratory for a long time. These days, tissue engineering enables us to build up artificial tissue, although science still hasn’t been successful with larger organs. Now, researchers at Fraunhofer are applying new techniques and materials to come up with artificial blood vessels in their BioRap project that will be able to supply artificial tissue and maybe even complex organs in…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/blood-vessels-from-your-printer
  • Article - 29/07/2011 14959_de.jpg

    Labor Dr. Merk und Kollegen - Viruses under control

    It is difficult to imagine how Ochsenhausen-based Labor Dr. Merk und Kollegen (LMK) would be able to develop, produce and test medical products for bacterial and viral contaminations without using cell cultures. The medium-sized company also produces viruses for testing and has stored more than 80 different viruses – enveloped and non-enveloped ones, animal and human pathogens – at -80˚C.

    https://www.gesundheitsindustrie-bw.de/en/article/news/labor-dr-merk-und-kollegen-viruses-under-control
  • Article - 18/07/2011 The photo shows an X-ray image of a jaw from the front; numerous screws with artificial teeth attached to them are shown in white.<br />

    Titanium screws and stem cells for dental implants

    How are we supposed to chew and smile when the tooth fairy comes to fetch our second set of teeth? When it’s difficult to tell the difference between modern tooth implants and real teeth in both technical and aesthetical terms, people who lose their teeth due to accidents or age very quickly regain their smile. However, there needs to be enough bone to hold and support the implant. Prof. Dr. Dr. Ralf Gutwald and his team in the Department of Oral…

    https://www.gesundheitsindustrie-bw.de/en/article/news/titanium-screws-and-stem-cells-for-dental-implants
  • Article - 04/07/2011 The photo shows a cuboid structure with rounded edges, corrugated surface and several lateral openings.

    Orthobion GmbH: biomaterials for spinal implants

    If one takes a closer look at the mechanisms involved in bone growth, it turns out that the supposedly simple issue as to how bones grow cannot be fully answered. Konstanz-based Orthobion GmbH investigates and produces targeted biomaterials for use in implants designed for the treatment of spinal column defects. The surface structures of materials and how they affect the adhesion of bones to implant surfaces are key issues in the production of…

    https://www.gesundheitsindustrie-bw.de/en/article/news/orthobion-gmbh-biomaterials-for-spinal-implants
  • Article - 04/07/2011 The biopolymers are turned into fibres in the institute's melt spinning plant and subsequently used for the production of textiles.<br />

    Synthetic tendons made from bicomponent fibres

    Organs are not the only things to be transplanted. Sometimes tendons also need to be replaced. At St. Gallen-based Empa (Swiss Federal Laboratories for Materials Science and Technology), an interdisciplinary team of scientists is working on the development of synthetic tendons for surgical applications. The synthetic tendons are made of bicomponent fibres that decompose efficiently in the body after implantation.

    https://www.gesundheitsindustrie-bw.de/en/article/news/synthetic-tendons-made-from-bicomponent-fibres
  • Article - 04/07/2011 Dr. Harald Stallforth, CEO Research & Development and Vice Chairman of the Aesculap AG management board

    The use of regenerative biomaterials is likely to grow

    Tuttlingen-based Aesculap AG is committed to using different materials including ceramics, titanium and high-performance polymers for the development and production of implants. The medical technology company has come up with a solution to prevent people from developing allergies against substances used in prostheses. Dr. Harald Stallforth, CEO Research & Development and Vice Chairman of the Aesculap AG management board talks with a BioLAGO…

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-use-of-regenerative-biomaterials-is-likely-to-grow
  • Article - 04/07/2011 14640_de.jpg

    The adhesion of cells to the endothelium and to artificial surfaces

    Professor Stefan W. Schneider from the Mannheim Medical Faculty is investigating the function of the vascular endothelium and its interaction with blood and tumour cells using microfluidics methods that enable him to measure the adhesion of cells to the walls of blood vessels under physiological flow conditions. As part of an interdisciplinary project, he is investigating the characteristics of wafer-thin surfaces covered with living cells, which…

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-adhesion-of-cells-to-the-endothelium-and-to-artificial-surfaces
  • Dossier - 04/07/2011 The cement-free Metha® Short Hip Stem prosthesis with Plasmapore® µ-CaP coating of the entire proximal surface supports rapid secondary fixation. µ-CaP is applied on the microporous titanium Plasmapore® surface. It has an osteoconductive effect and accelerates contact between the bone and the prosthesis stem.

    Implants of the future: bioactive, corrosion-resistant and antibacterial

    People’s life expectancy is increasing due to constantly improving medical treatment. One result of this is the greater wear of joints, which then need to be replaced with implants. Increased life expectancy means that the implants remain in the body for much longer and therefore need to be longer lasting. The revision rate of implant materials used in clinical practice is still as much as 10 per cent, particularly in the case of hip and knee…

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/implants-of-the-future-bioactive-corrosion-resistant-and-antibacterial
  • Article - 14/06/2011 14497_de.jpg

    Retinitis pigmentosa: a new form of cell death

    What form of cell death do the photoreceptors of people suffering from retinitis pigmentosa undergo and how can their degeneration be prevented or delayed with pharmaceutical substances? Dr. Paquet-Durand from the Institute for Ophthalmic Research in Tübingen is working to resolve these questions.

    https://www.gesundheitsindustrie-bw.de/en/article/news/retinitis-pigmentosa-a-new-form-of-cell-death

Page 3 / 6

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2022
Website address: https://www.gesundheitsindustrie-bw.de/en/search